Showing results (671-680 of 789) with videos related to
Sort By:
Pageof 79
Cancers|October 21, 2020
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with PertuzumabLaura L Michel, Andreas D Hartkopf, Peter A Fasching, et al.Geburtshilfe Und Frauenheilkunde|December 2, 2020
Correction: Treatment Landscape and Prognosis After Treatment with Trastuzumab EmtansineElena Laakmann, Julius Emons, Florin-Andrei Taran, et al.Cancers|December 23, 2018
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer RegistryMichael P Lux, Naiba Nabieva, Andreas D Hartkopf, et al.Journal of Cancer Research and Clinical Oncology|July 16, 2017
Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinomaStefan Kommoss, Andreas D Hartkopf, Bernhard Krämer, et al.European Journal of Cancer (Oxford, England : 1990)|July 26, 2021
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 statusAlexander Hein, Andreas D Hartkopf, Julius Emons, et al.European Journal of Cancer (Oxford, England : 1990)|June 21, 2022
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registryVolkmar Müller, Alexander Hein, Andreas D Hartkopf, et al.Geburtshilfe Und Frauenheilkunde|May 31, 2024
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT RegistryAndreas D Hartkopf, Christina B Walter, Hans-Christian Kolberg, et al.Geburtshilfe Und Frauenheilkunde|August 29, 2017
Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer RegistryMarkus Wallwiener, Felix Heindl, Sara Y Brucker, et al.Electrophoresis|April 29, 2006
Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detectionHans Neubauer, Susan E Clare, Raffael Kurek, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 1, 2013
SOX2 expression and prognostic significance in ovarian carcinomaDeborah L Pham, Veit Scheble, Petra Bareiss, et al.Pageof 79